Table 3.
Multivariate analysis of possible factors associated with neovascular glaucoma in central retinal vein occlusion patients.
| Parameters | Adjusted OR | 95% CI | p value |
|---|---|---|---|
| Age | 0.151 | ||
| Baseline best-corrected visual acuity | 0.695 | ||
| Baseline intraocular pressure | 0.194 | ||
| Baseline central retinal thickness | 0.853 | ||
| Baseline presence of subretinal fluid | 0.145 | ||
| Ischaemic type | 13.087 | 2.120–80.781 | 0.006* |
| Number of intravitreal bevacizumab injections during the past 6 months | 0.392 | ||
| 1-month follow-up central retinal thickness | 1.008 | 1.003–1.014 | 0.007* |
OR odds ratio, CI confidence interval.
*Statistically significant by binary logistic regression analysis with backward elimination method (R2 = 0.560, p = 0.831 by the Hosmer–Lemeshow test for goodness of fit).